Tinidazole was approved by the FDA in May 2004 for the treatment of trichomoniasis, giardiasis, amebiasis, and amebic liver abscess.

diff to respond to treatment and for diarrhea to clear ... administered a probiotic supplement showed a lower risk of Clostridium difficile infections. The study authors concluded moderate-quality ...

Rockville, MD, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The global Clostridium difficile infection treatment market has been estimated at US$ 1.24 billion for 2024 and is projected to expand at a CAGR of ...

Purpose The pharmacology, clinical efficacy, safety, dosage and administration, and place in therapy of fidaxomicin for the treatment of Clostridium difficile infection (CDI) are reviewed.

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

Q. My son picked up an infection in the hospital recently. It sounded like the doctors were calling it “see-dift.” It gave him terrible diarrhea. Do you know what this is? A. The doctors were ...

Antibiotics also increase the risk of Clostridioides difficile infection (previously called Clostridium difficile), often ... can occur during antibiotic treatment or up to several months after ...

Once C-diff is in the ascendancy it can be very hard to shift – the traditional treatment is antibiotics but a significant number of patients do not respond and are left with relentless and ...